Phenylpiracetam hydrazide, also known as fonturacetam hydrazide,[1] is a racetam that is a derivative of phenylpiracetam in which the amide group is replaced with a hydrazide group.

It was first reported by a Russian research group in 1980 as part of a series of chemical compounds investigated as anticonvulsants.

[2] All piracetam derivatives are not permitted to be sold as dietary supplements in the United States.

[3] However, because they lack scheduling, piracetam derivatives like phenylpiracetam hydrazide are sold over the clear net accompanied by indications stating that the compound is "not for human consumption".

[4] This anticonvulsant-related article is a stub.